TOP2A and neutropenia: Thus, to overcome the above-mentioned drug resistance and cardiotoxicity, combinatorial targeting of top1 and top2α is essential, but recent clinical data have shown that the combination of top1 and top2α poisons might lead to severe life-threatening neutropenia and anemia resulting from the toxicity overlay of the two agents [13].